Medicare keeps spending more on COVID-19 testing. Fraud and overspending are partly why
Medicare’s COVID-19 testing costs reached over $2 billion in 2022. The growing costs concern some experts, who say financial incentives and a lack of regulation early in the pandemic led to fraud and overspending.